Several studies, however, suggest a disconnection between NAFLD and MetS because overexpression of Diacylglycerol O-Acyltransferase 2 (DGAT2) led to marked hepatosteatosis, whereas glucose and insulin levels remained normal. The gene discussed is DGAT2; the disease is metabolic dysfunction-associated steatotic liver disease.